Study on the relationship between p16INK4a promoter hypermethylation of epidermis and clinical status in psoriasis

Journal of Clinical Dermatology

Volumn 35, Issue 8, 2006, Pages 489-491

  Chen, Min ^a   Li, An Sheng ^a   Cui, Pan Gen ^a   Ji, Jiang ^a   Li, Yu Mei ^a   Chen, Zhi Qiang ^a  

^a INSTITUTE OF DERMATOLOGY   (China)

Author keywords

Gene; Methylation; p16; Psoriasis

Indexed keywords

PROTEIN P16INK4A;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; EPIDERMIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PROMOTER REGION; PROTEIN METHYLATION; PSORIASIS; SCORING SYSTEM;

EID: 33749038632     PISSN: 10004963     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Chinese source. 2005, 38(9): 578-580.
2. Herman JG, Graff JR, Myohanen S, et al. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands [J]. Proc Natl Acad Sci USA, 1996, 93(18): 9821-9826.
3. Chinese source. 1999, 13(4): 208-209.
4. Chinese source. 1998, 31(2): 104-105.
5. van Doorn R, Gruis NA, Willemze R, et al. Aberrant DNA methylation in cutaneous malignancies[J]. Semin Oncol, 2005, 32 (5): 479-487.
6. Chinese source. 2005, 34 (4): 211-214.
7. Chinese source. 2004, 25(4): 330-332.
8. Chinese source. 2000, 33(2): 108-109.
9. Hartsough MT, Clare SE, Mair M, et al. Elevation of breast carcinoma Nm23-H1 metastasis suppressor gene expression and reduced motility by DNA methylation inhibition[J]. Cancer Res, 2001, 61(5): 2320-2327.